Reproduction permitted for personal use only. For reprints and reprint permission, contact email@example.com.
announces that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $100,000 from the National Institutes of Health. This 1-year funded project will enable the Company to further expand its cell motility assay product line into the High Througput Screening (HTS) market. By implementing modifications to Platypus' current Oris 96-well cell migration assay, the Company aims to make the proposed assay compatible with automated liquid handling systems and High Content Imaging (HCI) platforms. According to Renee Herber, Program Manager, This is an exciting project that will dramatically improve testing throughput and efficiency, while reducing the cost per assay for researchers. Platypus Technologies has received over $18 million in federal funding to develop cell-based assays for the study of cell motility, and LC-based nanotechnology products for environmental monitoring, infectious disease testing and homeland security.